← All stocks

Insmed Inc

INSMPharmaceuticalsLatest filing used: 2026-10-29Filings on SEC EDGAR ↗

Fast grower

Fair value per share

No filings-based value

Too few comparable years of filings.

Last close

$121.14

Nov 13, 2026

How we decide

Ten years of results

Revenue

$606M in FY2025, up 67% on the year before

FY2016: $0FY2017: $0FY2018: $10MFY2019: $136MFY2020: $164MFY2021: $188MFY2022: $245MFY2023: $305MFY2024: $364MFY2025: $606M$400M$800MFY16FY19FY22FY25$606M
Show as table
YearRevenue
FY2016$0
FY2017$0
FY2018$10M
FY2019$136M
FY2020$164M
FY2021$188M
FY2022$245M
FY2023$305M
FY2024$364M
FY2025$606M

Shares outstanding

Share count rose 222% over 9 years

FY2016: 62MFY2017: 67MFY2018: 77MFY2019: 85MFY2020: 98MFY2021: 112MFY2022: 123MFY2023: 140MFY2024: 164MFY2025: 199M0100M200MFY16FY19FY22FY25199M
Show as table
YearShares outstanding
FY201662M
FY201767M
FY201877M
FY201985M
FY202098M
FY2021112M
FY2022123M
FY2023140M
FY2024164M
FY2025199M

No cash earnings in the filings. No dividends paid in these years.

Delayed quote

Delayed price and chart from TradingView. This site does not receive or store these prices, and the fair value above does not use them. Showing the chart sends TradingView this page's address, the widget type, the ticker and your IP address, and TradingView may collect analytics; see Privacy.

Open on Yahoo Finance ↗

Sources. Company figures: SEC EDGAR (XBRL filings), latest filing used 2026-10-29. Interest rate: U.S. Treasury, 10-year par yield, 2026-11-13. Last close: IEX Historical Data, 2026-11-13.